Continuous Processing in Pharmaceutical Manufacturing


This paper provides an overview of the continuous processing landscape — from dealing with FDA to the intricacies of continuous chemical reactions. The authors, from Pfizer Inc.’s Pharmaceutical Sciences division, say the industry will change dramatically in the next decade.


Author: Matthew J. Mollan Jr., Ph.D. and Mayur Lodaya, Ph.D., Pfizer Inc.  | File Type: MS Word document

Find more white papers on Process OperationsAutomation & Control

View all white papers»